BLS Pharmaceuticals Limited (ASX:BLS)
Australia · Delayed Price · Currency is AUD 1.180
-0.025 (-2.07%)
Sep 22, 2026, 4:10 PM AEST
BLS Pharmaceuticals Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | 15.4 | 4.9 | -13.33 | -1.94 | -0.49 |
Depreciation & Amortization | 1.28 | 0.66 | 0.23 | 0.11 | 0.03 |
Other Amortization | 0.1 | 0.1 | 0.03 | - | - |
Loss (Gain) From Sale of Assets | 0.02 | - | 0.08 | - | - |
Asset Writedown & Restructuring Costs | - | - | 11.57 | 0.09 | 0.04 |
Stock-Based Compensation | 1.97 | 1.21 | 0.14 | 0.7 | 0.1 |
Provision & Write-off of Bad Debts | 0.25 | - | - | - | 0.01 |
Other Operating Activities | -0.12 | -0.26 | 0.04 | -0.38 | -0.07 |
Change in Accounts Receivable | -4.35 | -2.05 | -1.22 | -0.6 | -0.27 |
Change in Inventory | -14.21 | -1.46 | -1.15 | -0.92 | -0.08 |
Change in Accounts Payable | 4.89 | 2.12 | 0.04 | 1.81 | 0.21 |
Change in Unearned Revenue | 1.59 | 1.06 | - | - | - |
Change in Income Taxes | 0.02 | - | - | - | - |
Change in Other Net Operating Assets | -1.17 | - | - | - | - |
Operating Cash Flow | 5.41 | 6.28 | -3.56 | -1.13 | -0.51 |
Operating Cash Flow Growth | -13.73% | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -3.81 | -2.07 | -0.18 | -0.06 | -0.06 |
Cash Acquisitions | - | - | - | 4.16 | 0.09 |
Sale (Purchase) of Intangibles | -0.11 | - | -0.31 | - | - |
Investment in Securities | -0.09 | - | - | - | - |
Other Investing Activities | 0.45 | - | - | - | - |
Investing Cash Flow | -3.55 | -2.07 | -0.49 | 4.1 | 0.03 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Long-Term Debt Issued | 3.05 | 0.39 | - | 0.22 | 0.49 |
Long-Term Debt Repaid | -0.73 | -0.43 | -0.14 | - | - |
Lease Payments | -0.4 | -0.38 | -0.14 | - | - |
Net Debt Issued (Repaid) | 2.32 | -0.04 | -0.14 | 0.22 | 0.49 |
Issuance of Common Stock | 1.45 | 2.45 | 1.35 | 0.58 | - |
Financing Cash Flow | 3.76 | 2.42 | 1.21 | 0.81 | 0.49 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Foreign Exchange Rate Adjustments | -0.01 | 0.02 | 0.02 | 0 | -0.01 |
Net Cash Flow | 5.62 | 6.64 | -2.82 | 3.78 | 0 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 1.61 | 4.21 | -3.74 | -1.19 | -0.57 |
Free Cash Flow Growth | -61.82% | - | - | - | - |
Free Cash Flow Margin | 2.17% | 14.37% | -38.77% | -22.45% | -122.27% |
Free Cash Flow Per Share | 0.01 | 0.02 | -0.02 | -0.01 | -0.01 |
Levered Free Cash Flow | -1.86 | 4.38 | -2.61 | -0.54 | 0.03 |
Unlevered Free Cash Flow | -1.57 | 4.46 | -2.61 | -0.54 | 0.03 |
Free Cash Flow After Leases | 1.21 | 3.82 | -3.88 | -1.19 | -0.57 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | 0.46 | 0.13 | - | - | - |
Cash Income Tax Paid | - | - | - | -0.07 | - |
Change in Working Capital | -13.49 | -0.33 | -2.33 | 0.29 | -0.13 |